Share this article
Share this article
ResearchAndMarkets.com's offering.
The Multiplex factor is creating market confusion while lowering costs and improving care but important factors are holding back progress.
COVID-19 has broken open the market for point of care testing of respiratory infections. Now the competition for market share begins in earnest.
Large new markets are opening up. In health facilities, clinics, physicians' offices and elsewhere. And let's not forget the screening market, not just for COVID, but for the rest of the 20 something respiratory pathogens as well. Multiplex vs single plex? Explore the rapidly changing market as competitors jockey for position in new markets that are not yet well understood.